ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2022 American Transplant Congress

    Impact of MMaT Policy on Transplant for Hepatocellular Carcinoma at a Single Center

    S. Kodali1, D. W. Victor2, J. Corkrean2, A. Shetty2, C. Mobley2, M. Hobeika2, R. McMillan2, E. A. Graviss3, D. T. Nguyen3, R. McFadden4, V. Ankoma-Sey2, C. Egwim5, J. Galati2, A. Saharia2, R. M. Ghobrial2

    1Sherrie and Alan Conover Center for Liver Disease and Transplantation, Houston Methodist Hospital, Sugarland, TX, 2Sherrie and Alan Conover Center for Liver Disease and Transplantation, Houston Methodist Hospital, Houston, TX, 3Department of Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, TX, 4Department of Medicine, Hepatology, Houston Methodist Hospital, Houston, TX, 5Houston Methodist Hospital, Houston, TX

    *Purpose: Hepatocellular carcinoma (HCC) is the most common primary malignant hepatic tumor. Currently, liver transplantation may be the optimal treatment for HCC. Patient selection criteria…
  • 2022 American Transplant Congress

    Landscape of Attitudes Towards Living Kidney Donation During the SARS-CoV-2 Pandemic in the United States: Results of a Public Opinion Survey

    K. Kaplow1, J. Ruck1, A. Thomas1, D. Warren1, D. Segev1, C. Corlett2, J. Sinacore3, M. Levan1

    1Department of Surgery, The Johns Hopkins University School of Medicine, Baltimore, MD, 2Brand Planning LLC, Williamsburg, VA, 3National Kidney Registry, Babylon, NY

    *Purpose: Solid organ transplantation decreased during the SARS-CoV-2 pandemic largely due to temporary shutdowns. The pandemic revealed significant gaps in medical knowledge among the public;…
  • 2022 American Transplant Congress

    A2/A2B to B Kidney Transplantation Outcomes: A Single-Center 5 Year Experience

    A. El Chediak, S. Shawar, M. Fallahzadeh, I. Feurer, S. Rega, J. L. Triozzi, D. Shaffer

    Vanderbilt University Medical Center, Nashville, TN

    *Purpose: The new kidney allocation system (KAS) instituted in 2014 allowed organ procurement organizations to allocate A2/A2B to B candidates preferentially was meant to improve…
  • 2022 American Transplant Congress

    High Resolution Typing Can Improve Accuracy and Sensitivity of the Virtual Crossmatch for Sensitized Patients – A Single Center’s Experience

    C. MarElia-Bennett1, V. Rohan2, K. Twombley3, O. Moussa1

    1Pathology & Laboratory Medicine, Medical University of South Carolina, Charleston, SC, 2Surgery, Medical University of South Carolina, Charleston, SC, 3Medical University of South Carolina, Charleston, SC

    *Purpose: The introduction of solid phase assays has significantly enhanced our ability to execute virtual crossmatches (VXMs). However, this method is not without its shortcomings.…
  • 2022 American Transplant Congress

    Pharmacogenomic Dosing in Kidney Transplant Patients Converted from Tacrolimus Immediate Release to Tacrolimus Extended Release (Envarsus XR®)

    K. D. Belfield1, K. J. Armstrong2, D. Malhotra3, G. F. Girone1

    1Department of Pharmacy, Yale New Haven Hospital, New Haven, CT, 2Department of Pharmacy, Hospital of Central Connecticut, New Britain, CT, 3Section of Nephrology, Yale School of Medicine, New Haven, CT

    *Purpose: When converting from tacrolimus (tac) immediate release (tacIR) to tac extended release (Envarsus XR; tacXR), the package insert (PI) recommends 80% of the tacIR…
  • 2022 American Transplant Congress

    Outcome of Living Donor Kidney Transplant and Deceased Donor Kidney Transplant: A Retrospective Cohort Study at National Kidney and Transplant Institute

    A. B. Burog, A. Parayno

    ORGAN TRANSPLANTATION AND VASCULAR SURGERY, National Kidney And Transplant Institute, Quezon City, Philippines

    *Purpose: To compare the graft and patient survival of living and deceased donor kidney transplant and identify the factors that affect graft survival.*Methods: Retrospective cohort…
  • 2022 American Transplant Congress

    Molecular ABO Typing: An Effective Tool for Resolving Deceased Donor Indeterminate ABO Types

    D. Tanglao1, S. S. Musa1, J. J. Chew1, L. Santiago2, K. Herron3, B. O'Neale3, N. A. Lemp1, S. O. Dionne4

    1Eurofins DPT, Los Angeles, CA, 2Eurofins DPT, Centennial, CO, 3Eurofins DPT, Centennial, CA, 4Eurofins DPT, denver, CO

    *Purpose: In order to evaluate molecular ABO typing as an alternative method of blood typing that may be employed when indeterminate serological typing results are…
  • 2022 American Transplant Congress

    Evaluation of Compliance and Efficacy with Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for Tacrolimus in Kidney Transplant Recipients

    M. Nikirk1, J. Chen1, E. Tillman2

    1Indiana University Health, Indianapolis, IN, 2Indiana University School of Medicine, Indianapolis, IN

    *Purpose: The purpose of this study is to evaluate compliance and efficacy of The Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for CYP3A5 genotype guided tacrolimus…
  • 2022 American Transplant Congress

    A Dose Dependent Effect of Varying Tacrolimus Concentrations on Cytomegalovirus Viral Specific T Cell Interferon Gamma Expression

    H. L. Kleiboeker1, M. R. Jorgenson1, R. O. Meyers2, O. Ganz2, S. Parajuli3, J. Galipeau4

    1Pharmacy, University of Wisconsin Hospital and Clinics, Madison, WI, 2Program for Advanced Cell Therapy, University of Wisconsin Hospital and Clinics and School of Medicine and Public Health, Madison, WI, 3Medicine, Division of Nephrology, University of Wisconsin School of Medicine and Public Health, Madison, WI, 4Medicine, Division of Hematology and Oncology, University of Wisconsin School of Medicine and Public Health, Madison, WI

    *Purpose: Tacrolimus, considered the backbone of transplant immunosuppression, is associated with increased risk of viral infections, including cytomegalovirus (CMV), due to its potent inhibitory effect…
  • 2022 American Transplant Congress

    Experience with Covid-19 Infection and Vaccination in Combined Kidney/HSCT Recipients

    M. Gibson1, D. Belshe1, G. Gregory1, S. Tanna1, M. Ison1, S. Ildstad2, J. R. Leventhal1

    1Northwestern University, Chicago, IL, 2University of Louisville, Louisville, KY

    *Purpose: Kidney transplant(KTx) recipients are at increased risk of COVID-19 related complications. KTx pts who have undergone therapy to induce tolerance are a unique cohort…
  • « Previous Page
  • 1
  • …
  • 130
  • 131
  • 132
  • 133
  • 134
  • …
  • 1683
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences